Literature DB >> 4101425

Comparison of treatment policies in inoperable bronchial carcinoma.

K R Durrant, R J Berry, F Ellis, F R Ridehalgh, J M Black, W S Hamilton.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 4101425     DOI： 10.1016/s0140-6736(71)91986-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Lung cancer: to treat or not to treat?

Authors:  M Goldberg
Journal:  Can Fam Physician       Date:  1985-06       Impact factor: 3.275

2.  London letter.

Authors:  S S Gilder
Journal:  Can Med Assoc J       Date:  1971-06-19       Impact factor: 8.262

3.  Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group.

Authors:  M F Muers; C E Round
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

Review 4.  Is the use of chemotherapy justified in non-small-cell lung cancer?

Authors:  P Kelly; L Clancy
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

5.  [Lung cancer--hopelessness in inoperability? A 10-year follow-up].

Authors:  N Schwegler
Journal:  Strahlenther Onkol       Date:  1997-07       Impact factor: 3.621

Review 6.  Radiotherapy in the management of non-small-cell lung cancer.

Authors:  A Bezjak; D Payne
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

7.  Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial.

Authors:  Stephen J Falk; David J Girling; Roger J White; Penelope Hopwood; Angela Harvey; Wendi Qian; Richard J Stephens
Journal:  BMJ       Date:  2002-08-31

8.  A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer.

Authors:  R L Woods; C J Williams; J Levi; J Page; D Bell; M Byrne; Z L Kerestes
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

9.  Palliation and life quality in lung cancer; how good are clinicians at judging treatment outcome?

Authors:  J Regan; J Yarnold; P W Jones; N T Cooke
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

10.  Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.

Authors:  W K Evans; B P Will; J M Berthelot; M C Wolfson
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.